Literature DB >> 16272071

Cost of heart failure in Swedish primary healthcare.

Björn Agvall1, Lars Borgquist, Mats Foldevi, Ulf Dahlström.   

Abstract

OBJECTIVES: To calculate the cost for patients with heart failure (HF) in a primary healthcare setting.
DESIGN: Retrospective study of all available patient data during a period of one year.
SETTING: Two healthcare centers in Linköping in the southeastern region of Sweden, covering a population of 19 400 inhabitants.
SUBJECTS: A total of 115 patients with a diagnosis of HF. MAIN OUTCOME MEASURES: The healthcare costs for patients with HF and the healthcare utilization concerning hospital days and visits to doctors and nurses in hospital care and primary healthcare.
RESULTS: The mean annual cost for a patient with HF was SEK 37 100. There were no significant differences in cost between gender, age, New York Heart Association functional class, and cardiac function. The distribution of cost was 47% for hospital care, 22% for primary healthcare, 18% for medication, 5% for nursing home, and 6% for examinations.
CONCLUSION: Hospital care accounts for the largest cost but the cost in primary healthcare is larger than previously shown. The total annual cost for patients with HF in Sweden is in the range of SEK 5.0-6.7 billion according to this calculation, which is higher than previously known.

Entities:  

Mesh:

Year:  2005        PMID: 16272071     DOI: 10.1080/02813430500197647

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  17 in total

1.  Systematic review of economic burden of heart failure.

Authors:  Asrul Akmal Shafie; Yui Ping Tan; Chin Hui Ng
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

2.  Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitus.

Authors:  Hillary R Bogner; Steven D Miller; Heather F de Vries; Sumedha Chhatre; Ravishankar Jayadevappa
Journal:  J Card Fail       Date:  2010-03-06       Impact factor: 5.712

Review 3.  Economic burden of heart failure in the elderly.

Authors:  Lawrence Liao; Larry A Allen; David J Whellan
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

4.  Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension.

Authors:  Ola Granström; Lars-Åke Levin; Martin Henriksson
Journal:  Clinicoecon Outcomes Res       Date:  2012-11-01

5.  Atrial fibrillation: the cost of illness in Sweden.

Authors:  Lisa Ericson; Lennart Bergfeldt; Ingela Björholt
Journal:  Eur J Health Econ       Date:  2010-07-01

6.  Ventricular longitudinal function by cardiovascular magnetic resonance predicts cardiovascular morbidity in HFrEF patients.

Authors:  Jonathan Berg; Julius Åkesson; Robert Jablonowski; Kristian Solem; Einar Heiberg; Rasmus Borgquist; Håkan Arheden; Marcus Carlsson
Journal:  ESC Heart Fail       Date:  2022-04-11

7.  Body weight in midlife and long-term risk of developing heart failure-a 35-year follow-up of the primary prevention study in Gothenburg, Sweden.

Authors:  Lena Björck; Masuma Novak; Maria Schaufelberger; Kok Wai Giang; Annika Rosengren
Journal:  BMC Cardiovasc Disord       Date:  2015-03-10       Impact factor: 2.298

8.  Bariatric Surgery can Lead to Net Cost Savings to Health Care Systems: Results from a Comprehensive European Decision Analytic Model.

Authors:  Oleg Borisenko; Daniel Adam; Peter Funch-Jensen; Ahmed R Ahmed; Rongrong Zhang; Zeynep Colpan; Jan Hedenbro
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

9.  Consequences of high-sensitivity troponin T testing applied in a primary care population with chest pain compared with a commercially available point-of-care troponin T analysis: an observational prospective study.

Authors:  Per O Andersson; Jan-Erik Karlsson; Eva Landberg; Karin Festin; Staffan Nilsson
Journal:  BMC Res Notes       Date:  2015-06-03

10.  Development of an economic model to assess the cost-effectiveness of hawthorn extract as an adjunct treatment for heart failure in Australia.

Authors:  Emily Ford; Jon Adams; Nicholas Graves
Journal:  BMJ Open       Date:  2012-09-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.